AzTrials
AzTrials

Colorectal PolypNCT04754347

Computer Aided Detection of Polyps in Colonoscopy

A study testing Computer Aided Detection device in people with Colorectal Polyp, run by Iterative Scopes, Inc at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to evaluate the clinical benefit and safety of using a computer aided detection device, Skout, for real-time polyp detection in colonoscopy procedures with the indication of screening or surveillance. Read more about this study

Who is it for?
Ages 40 years and older
Conditions the study is for
Colorectal Polyp
What is being tested?
Computer Aided Detection device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,472 participants
Where
5 sitesUnited States
Study dates
22 Jan 2021to 31 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participants will be eligible for this study if they are:
  • Undergoing colonoscopy with screening, surveillance, or diagnostic indications.
  • Undergoing a procedure by a participating endoscopist.
  • Have given informed consent.

Who cannot join

  • Participants will not be eligible for this study if they:
  • Have a history of inflammatory bowel disease.
  • Have a history of familial adenomatous polyposis.
  • Are under the age of 40.
  • Have had a colonoscopy within the previous three (3) years.
  • Undergoing diagnostic colonoscopy with high-risk indications including iron deficiency anemia, abnormal CT imaging, unexplained weight loss, Lynch Syndrome, blood in stool or FIT positive test.
  • Entered with poor bowel preparation (inadequate for procedure as assessed by the Investigator).
  • Use anti-platelet agents or anticoagulants that preclude the removal of polyps during the procedure.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

  • Boston Medical Center

    Boston, Massachusetts, 02118

  • Mount Auburn Hospital

    Cambridge, Massachusetts, 02138

  • Concord Endoscopy Center

    Concord, New Hampshire, 03301

  • MNGI Digestive Health

    Plymouth, Minnesota, 55446

Other trials in United States

About this study

Official title: Randomized, Controlled Trial of a Computer Aided Detection Device in Standard Colonoscopy

The aim of this study is to evaluate the clinical benefit and safety of using a computer aided detection device, Skout, for real-time polyp detection in colonoscopy procedures with the indication of screening or surveillance. One of the reasons for the development of interval colorectal cancers is polyps missed during colonoscopy. Our hypothesis is that with the aid of Skout, the adenomas detected per colonoscopy will increase, and it is plausible to believe that this increase in detection could reduce the incidence of interval cancers.

Being tested
Computer Aided Detection device
Keywords
Screening Colonoscopy, Artificial Intelligence, Computer Aided Detection, Adenoma Detection Rate, Adenomas per Colonoscopy, Surveillance Colonoscopy, Colorectal Cancer, Software as a Medical Device
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computer Aided Detection deviceDevice

    The Computer Aided Detection device, Skout, is designed to help endoscopists detect potential colorectal polyps during colonoscopies. The system performs automated real-time analysis on endoscopic video data to identify potential polyps and produces an informational visual aid around the appropriate sections of the video frames on a display monitor.

Study groups in NCT04754347
Study groupRoleWhat they receive
ControlNo interventionRoutine Colonoscopy
ExperimentalExperimentalRoutine Colonoscopy with the use of Skout
Receives: Device: Computer Aided Detection device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adenomas per colonoscopy

    The total number of adenomas detected divided by the total number of colonoscopies.

    Measured: At the end of the procedure, 1 day

  2. Positive predictive value

    The total number of adenomas and serrated lesions detected divided by the total number of extractions.

    Measured: At the end of the procedure, 1 day

Secondary outcomes (3)
  1. Adenoma detection rate

    The percentage of participants aged ≥50 years undergoing first-time screening colonoscopy who have one or more conventional adenomas detected.

    Measured: At the end of the procedure, 1 day

  2. Sessile serrated lesions detected

    The total number of polyps with histology or serrated adenoma, traditional serrated adenoma or serrated lesion with cytological dysplasia, excluding hyperplastic polyps.

    Measured: At the end of the procedure, 1 day

  3. Colorectal cancer surveillance interval

    The mean recommended timeframe for follow up colonoscopy.

    Measured: At the end of the procedure, 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2021
  2. Study start22 Jan 2021
  3. Primary completion31 Oct 2021
  4. Study completion31 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
1,472 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04754347
Sponsor's protocol ID
Pro00047634
Status last verified
Nov 2021
First submitted
10 Feb 2021
Last updated
1 Dec 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Publications

  • Shaukat A, Lichtenstein DR, Somers SC, Chung DC, Perdue DG, Gopal M, Colucci DR, Phillips SA, Marka NA, Church TR, Brugge WR; SKOUT Registration Study Team. Computer-Aided Detection Improves Adenomas per Colonoscopy for Screening and Surveillance Colonoscopy: A Randomized Trial. Gastroenterology. 2022 Sep;163(3):732-741. doi: 10.1053/j.gastro.2022.05.028. Epub 2022 May 25.

    PubMed 35643173

Questions about this trial

What is this clinical trial studying?

A study testing Computer Aided Detection device in people with Colorectal Polyp, run by Iterative Scopes, Inc at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Dec 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adenomas per colonoscopy (time frame: At the end of the procedure, 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04754347, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Dec 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in